AKBA
Akebia Therapeutics, Inc. · Healthcare
SVP and Chief Medical Officer Steven Keith Burke sold $31K of Akebia Therapeutics, Inc.
Sold$31,050
$1.15Price
27,000Shares
−4%Stake
What AKBA did after the filing
- The stock from Thu, May 9 close, $1.33
- −32.0%
- S&P 500, same days
- +4.7%
Measured over 30 trading days, to the Jun 24 close.
Traded Fri, Aug 25. Filed Thu, May 9, 1:27 PM ET, during the session. Returns use the May 9 close and the Jun 24 close. Not investment advice.